Literature DB >> 6301738

Clinical pharmacokinetics of systemic antifungal drugs.

T K Daneshmend, D W Warnock.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6301738     DOI： 10.2165/00003088-198308010-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  134 in total

1.  Rapid determination of serum 5-fluorocytosine levels by high-performance liquid chromatography.

Authors:  R B Diasio; M E Wilburn; S Shadomy; A Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  Pharmacokinetics of imidazole antimycotics.

Authors:  M Plempel
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

3.  Use of antibiotics. Antifungals.

Authors:  R Y Cartwright
Journal:  Br Med J       Date:  1978-07-08

4.  Erythropoietin concentration in amphotericin B-induced anemia.

Authors:  R R MacGregor; J E Bennett; A J Erslev
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

5.  Simple assay for 5-fluorocytosine in the presence of amphotericin B.

Authors:  C A Kauffman; J A Carleton; P T Frame
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

6.  Impairing effect of food on ketoconazole absorption.

Authors:  P T Männistö; R Mäntylä; S Nykänen; U Lamminsivu; P Ottoila
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

7.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06

8.  Pharmacokinetics of amphotericin B and flucytosine.

Authors:  A Polak
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

9.  Progressive disseminated histoplasmosis; favorable response to ketoconazole.

Authors:  S S Hawkins; D W Gregory; R H Alford
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

10.  Dopamine and saralasin antagonism of renal vasoconstriction and oliguria caused by amphotericin B in dogs.

Authors:  N E Reiner; W L Thompson
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226
View more
  37 in total

1.  Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women.

Authors:  Mia Birkhøj Kjærstad; Flemming Nielsen; Lene Nøhr-Jensen; Stine Zwisler; Kim Brøsen; Helle Raun Andersen
Journal:  Eur J Clin Pharmacol       Date:  2010-10-06       Impact factor: 2.953

Review 2.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

3.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

4.  Antagonisms of potential concern in the clinical use of antifungal imidazoles and related azole-type drugs.

Authors:  W H Beggs
Journal:  Mycopathologia       Date:  1992-12       Impact factor: 2.574

Review 5.  Pharmacokinetics of newer drugs in patients with renal impairment (Part I).

Authors:  J P Fillastre; E Singlas
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

6.  Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone.

Authors:  Anders Lignell; Elisabeth Löwdin; Otto Cars; Dominique Sanglard; Jan Sjölin
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

7.  Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates.

Authors:  T J Walsh; C Lester-McCully; M G Rinaldi; J E Wallace; F M Balis; J W Lee; P A Pizzo; D G Poplack
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.

Authors:  Joseph Meletiadis; Jacques F G M Meis; Johan W Mouton; Juan Luis Rodriquez-Tudela; J Peter Donnelly; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

9.  Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.

Authors:  R E Lewis; B C Lund; M E Klepser; E J Ernst; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.

Authors:  W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.